Thyroid Pills Recalled Due to Potential 'Super Potency' and Risk of Hyperthyroidism
· Telemundo McAllen (KTLM)
Pharmaceutical company Vitruvias Therapeutics Inc. has issued a nationwide voluntary recall of a thyroid medication after it was found that the tablets could be 'super potent'; the pills, intended to treat hypothyroidism, could lead to hyperthyroidism if taken. The recall applies to lot 504950 of 30 mg thyroid tablets that were prescribed to patients. According to a statement from the Food and Drug Administration (FDA), Vitruvias Therapeutics is 'proactively notifying its wholesalers via email and phone to suspend distribution of the product.' The company indicated it is coordinating the destruction of the recalled tablets but warned patients not to stop taking the medication without consulting their doctor first. The tablets were distributed nationwide from January 31, 2025, to September 30, 2025. A complete description of the recalled product and its label can be found below. Product NDC Lot Expiration Date Units Released Units Sold First Distribution Date Last Distribution Date Thyroid Tablets, USP 30 mg 69680-166-00 504950 09/30/2026 3,655 1,955 01/31/2025 09/30/2025 The recall comes weeks after another recall was issued for levothyroxine sodium tablets, a prescription thyroid medication from Major Pharmaceuticals, after some pills were found to be 'subpotent,' containing less active ingredients. Taking super potent thyroid tablets can lead to hyperactivity of the thyroid, the announcement stated, causing various adverse health effects, including heat intolerance, fatigue, nervousness, muscle weakness, hypertension, chest pain, rapid heartbeat, or heart rhythm disturbances. The population at higher risk includes elderly patients and pregnant individuals, as excessive levels of thyroid hormones can lead to heart problems and higher rates of maternal-fetal complications. According to the manufacturer, no adverse or harmful health events related to this recall have been reported.
AI summary · Source: Telemundo McAllen (KTLM) →
